VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VYGR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VYGRVoyager Therapeutics, Inc.
$3.62$219M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVYGRQuarterly Financials

Voyager Therapeutics, Inc. (VYGR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Voyager Therapeutics, Inc. (VYGR) quarterly income statement — complete revenue, gross profit & net income history

VYGR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue2.59M15.34M13.37M5.2M6.47M6.28M24.63M29.58M19.52M90.06M4.61M4.85M150.48M-1.55M41.09M712K658K28.07M1.48M1.36M
Revenue Growth %-59.94%144.28%-45.73%-82.42%-66.83%-93.03%433.79%509.48%-87.03%5910.39%-88.77%581.6%22769.3%-105.52%2672.33%-47.53%-89.88%329.45%-98.74%-95.27%
Cost of Goods Sold932K00000031.95M1.2M1.33M25.86M21.98M18.57M14.55M19.34M12.53M14.35M14.02M17.91M19.5M
COGS % of Revenue35.94%------108.03%6.13%1.48%560.53%453.02%12.34%-938.77%47.06%1759.41%2180.7%49.94%1208.77%1437.36%
Gross Profit1.66M15.34M13.37M5.2M6.47M6.28M24.63M-2.37M18.32M88.73M-21.25M-17.13M131.91M-16.1M21.75M-11.81M-13.69M14.05M-16.43M-18.15M
Gross Margin %64.06%100%100%100%100%100%100%-8.03%93.87%98.52%-460.53%-353.02%87.66%1038.77%52.94%-1659.41%-2080.7%50.06%-1108.77%-1337.36%
Gross Profit Growth %-74.34%144.28%-45.73%319.04%-64.67%-92.92%215.91%86.14%-86.11%651.06%-197.7%-45%1063.49%-214.57%232.36%34.9%13.59%190.91%-117.71%-2345.82%
Operating Expenses31.93M45.27M43.96M41.83M41.17M44.58M38.41M12.65M34.5M34.66M8.26M8.29M9.03M8.46M7.31M7.55M7.66M8.35M8.71M10.44M
OpEx % of Revenue1231.43%295.17%328.91%804.33%635.96%710.05%155.95%42.77%176.79%38.49%178.98%170.9%6%-545.94%17.78%1060.67%1163.98%29.75%587.99%769.12%
Selling, General & Admin8.26M9.32M8.09M10.49M9.64M8.99M8.17M10.15M8.61M10.24M8.26M8.29M9.03M8.46M7.31M7.55M7.66M8.35M8.71M10.44M
SG&A % of Revenue318.59%60.75%60.55%201.83%148.93%143.26%33.16%34.32%44.1%11.37%178.98%170.9%6%-545.94%17.78%1060.67%1163.98%29.75%587.99%769.12%
Research & Development24.6M35.95M35.87M31.33M31.53M35.58M30.24M34.45M25.9M24.42M25.86M21.98M18.57M14.55M19.34M12.53M14.35M14.02M17.91M19.5M
R&D % of Revenue948.79%234.43%268.36%602.5%487.04%566.79%122.79%116.48%132.69%27.12%560.53%453.02%12.34%-938.77%47.06%1759.41%2180.7%49.94%1208.77%1437.36%
Other Operating Expenses-932K000000-1000K00-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-30.27M-29.93M-30.59M-36.63M-34.69M-38.3M-13.78M-15.03M-16.18M54.06M-29.51M-25.43M122.88M-24.56M14.44M-19.37M-21.35M5.7M-25.15M-28.59M
Operating Margin %-1167.37%-195.17%-228.91%-704.33%-535.96%-610.05%-55.95%-50.8%-82.92%60.03%-639.51%-523.92%81.66%1584.71%35.15%-2720.08%-3244.68%20.31%-1696.76%-2106.48%
Operating Income Growth %12.75%21.85%-122.02%-143.76%-114.38%-170.84%53.3%40.91%-113.17%320.1%-304.31%-31.29%675.57%-530.78%157.43%32.25%16.57%124.03%-129.75%-218.28%
EBITDA-29.34M-28.88M-29.66M-35.56M-33.68M-37.29M-12.65M-13.63M-14.99M55.4M-28.56M-24.34M123.96M-23.73M15.78M-18.16M-18.54M7.18M-23.92M-27.4M
EBITDA Margin %-1131.43%-188.33%-221.94%-683.85%-520.3%-593.95%-51.35%-46.09%-76.79%61.51%-619.03%-501.55%82.38%1530.9%38.41%-2550.98%-2817.33%25.59%-1614.17%-2019.16%
EBITDA Growth %12.89%22.54%-134.52%-160.84%-124.72%-167.31%55.72%43.99%-112.09%333.46%-280.97%-34.01%768.68%-430.3%165.98%33.71%23.76%131.59%-127.95%-240.16%
D&A (Non-Cash Add-back)932K1.05M932K1.06M1.01M1.01M1.13M1.39M1.2M1.33M945K1.09M1.07M834K1.34M1.2M2.81M1.48M1.22M1.19M
EBIT-30.27M-29.93M-27.81M-36.63M-34.69M-38.3M-13.78M-12.53M-16.18M57.22M-29.51M-25.43M122.88M-24.56M14.44M-19.37M-21.35M5.7M-25.15M-28.59M
Net Interest Income1.91M2.11M2.38M2.83M3.29M3.99M4.58M4.89M4.87M3.15M3.43M3.27M1.86M976K545K219K31K-643K121K48K
Interest Income1.91M2.11M2.38M2.83M3.29M3.99M4.58M4.89M4.87M3.15M3.43M3.27M1.86M976K545K219K31K0121K48K
Interest Expense00000000000000000643K00
Other Income/Expense2.35M2.52M2.79M3.26M3.71M4.4M4.78M4.91M4.87M3.15M3.78M3.28M1.86M953K3.18M280K31K7K9K-1.53M
Pretax Income-27.92M-27.42M-27.81M-33.37M-30.98M-33.9M-9M-10.12M-11.32M57.22M-25.72M-22.15M124.75M-23.61M17.62M-19.09M-21.32M5.71M-25.14M-30.12M
Pretax Margin %-1076.86%-178.78%-208.07%-641.67%-478.67%-540.03%-36.55%-34.2%-57.98%63.53%-557.52%-456.4%82.9%1523.23%42.9%-2680.76%-3239.97%20.34%-1696.15%-2219.6%
Income Tax14K9K83K15K37K584K43K24K14K822K177K59K704K16K000000
Effective Tax Rate %-0.05%-0.03%-0.3%-0.04%-0.12%-1.72%-0.48%-0.24%-0.12%1.44%-0.69%-0.27%0.56%-0.07%0%0%0%0%0%0%
Net Income-27.94M-27.43M-27.89M-33.38M-31.02M-34.49M-9.04M-10.14M-11.33M56.4M-25.9M-22.21M124.04M-23.63M17.62M-19.09M-21.32M5.71M-25.14M-30.12M
Net Margin %-1077.4%-178.83%-208.69%-641.96%-479.24%-549.33%-36.72%-34.29%-58.05%62.62%-561.36%-457.61%82.43%1524.26%42.9%-2680.76%-3239.97%20.34%-1696.15%-2219.6%
Net Income Growth %9.94%20.47%-208.4%-229.18%-173.8%-161.15%65.08%54.34%-109.13%338.7%-246.96%-16.35%681.85%-513.84%170.11%36.63%1.52%135.85%-129.36%-246.96%
Net Income (Continuing)-27.94M-27.43M-27.89M-33.38M-31.02M-34.49M-9.04M-10.14M-11.33M56.4M-25.9M-22.21M124.04M-23.63M17.62M-19.09M-21.32M5.71M-25.14M-30.12M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.47-0.47-0.47-0.57-0.53-0.59-0.16-0.18-0.201.25-0.59-0.512.94-0.610.45-0.49-0.560.15-0.67-0.80
EPS Growth %11.32%20.34%-193.75%-216.67%-165%-147.2%72.88%64.71%-106.8%304.92%-231.11%-4.08%625%-506.67%167.16%38.75%3.45%134.88%-129.52%-247.83%
EPS (Basic)-0.47-0.47-0.47-0.57-0.53-0.59-0.16-0.18-0.201.28-0.59-0.513.05-0.610.46-0.49-0.560.15-0.67-0.80
Diluted Shares Outstanding59.5M58.69M58.8M58.67M58.35M57.97M57.85M57.72M57.12M45.08M43.86M43.52M42.16M38.55M39.57M38.3M38.05M37.8M37.78M37.58M
Basic Shares Outstanding59.5M58.69M58.8M58.67M58.35M57.97M57.85M57.72M57.12M43.98M43.86M43.52M40.63M38.55M38.51M38.17M38.05M37.8M37.52M37.58M
Dividend Payout Ratio--------------------